Kenya recalls Benylin cough syrup over safety concerns
Health & Science
By
Winfrey Owino
| Apr 11, 2024
The Pharmacy and Poisons Board (PPB) has directed outlets countrywide to stop the distribution of Benylin, a popular brand of children's cough syrup.
Benylin is a product of South African-based pharmaceutical company, Johnson and Johnson.
In a statement by Pharmacy Board, Chief Executive Fred Siyoi said the drug is under scrutiny over its safety and suitability for the Kenyan market.
The board says the decision was reached at after its Nigerian counterpart recalled the drug over safety issues.
READ MORE
KRA could miss out on millions in tax revenue from Zuku sale
Banks rush to comply with CBK rule on spying customer deals
Varying standards curtail Kenyan insurers' regional foray
Kenya and Algeria to expand trade agreements, Mudavadi says
Report: How Kenya's weak labour market hurts economy
Humanitarian agency banks on annual learning event to drive innovation, growth
New KPCU advances Sh125 million cherry fund loans to coffee farmers
Tea farmers earn Sh648 million from weekly auction
Why Mbadi's budget review is all about lowering expectations
Why Kenya-Germany jobs deal is double-edged sword for workers
- DCI barred from probing civil society over claims of funding protests
- Is your poultry structure ideal in this rainy season?